Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations

The disclosure relates to compounds of Formula I or a pharmaceutically acceptable salt thereof, wherein, m, R1-R5, R5A, and L are defined herein.These compounds are useful in methods for stabilizing a mutant PAH protein or reducing blood phenylalanine concentration in a subject suffering from phenyl...

Full description

Saved in:
Bibliographic Details
Main Authors Konteatis, Zenon D, De Pascalis, Lucrezia, King, Sandra, Shook, Brian C, Finlay, Heather Jane
Format Patent
LanguageEnglish
Published 05.03.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The disclosure relates to compounds of Formula I or a pharmaceutically acceptable salt thereof, wherein, m, R1-R5, R5A, and L are defined herein.These compounds are useful in methods for stabilizing a mutant PAH protein or reducing blood phenylalanine concentration in a subject suffering from phenylketonuria. In some embodiments, the mutant PAH protein contains at least one R408W, R261Q, R243Q, Y414C, L48S, A403V, I65T, R241C, L348V, R408Q, or V388M mutation. In other embodiments, the mutant PAH protein contains at least one R408W, Y414C, I65T, F39L, R408Q, L348V, R261Q, A300S, or L48S mutation.
AbstractList The disclosure relates to compounds of Formula I or a pharmaceutically acceptable salt thereof, wherein, m, R1-R5, R5A, and L are defined herein.These compounds are useful in methods for stabilizing a mutant PAH protein or reducing blood phenylalanine concentration in a subject suffering from phenylketonuria. In some embodiments, the mutant PAH protein contains at least one R408W, R261Q, R243Q, Y414C, L48S, A403V, I65T, R241C, L348V, R408Q, or V388M mutation. In other embodiments, the mutant PAH protein contains at least one R408W, Y414C, I65T, F39L, R408Q, L348V, R261Q, A300S, or L48S mutation.
Author De Pascalis, Lucrezia
Shook, Brian C
King, Sandra
Konteatis, Zenon D
Finlay, Heather Jane
Author_xml – fullname: Konteatis, Zenon D
– fullname: De Pascalis, Lucrezia
– fullname: King, Sandra
– fullname: Shook, Brian C
– fullname: Finlay, Heather Jane
BookMark eNqNijsOwjAMQDPAwO8O5gAMATF0pQIxIgFzZahDIyV2VCcS5fR04ABM7z3pzc2EhWlmLrXEJIVbBeQWIuVORi9KrgRw0oNmfPjgP55fkDriIWBA9kzQDW0v77GVIJaM2Qvr0kwdBqXVjwuzPh1v9XlDSRrShE9iys39am1lq8ruD9vdP88XYOs6kw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US11919915B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US11919915B23
IEDL.DBID EVB
IngestDate Fri Sep 20 10:13:04 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US11919915B23
Notes Application Number: US202318214831
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240305&DB=EPODOC&CC=US&NR=11919915B2
ParticipantIDs epo_espacenet_US11919915B2
PublicationCentury 2000
PublicationDate 20240305
PublicationDateYYYYMMDD 2024-03-05
PublicationDate_xml – month: 03
  year: 2024
  text: 20240305
  day: 05
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Agios Pharmaceuticals, Inc
RelatedCompanies_xml – name: Agios Pharmaceuticals, Inc
Score 3.5209198
Snippet The disclosure relates to compounds of Formula I or a pharmaceutically acceptable salt thereof, wherein, m, R1-R5, R5A, and L are defined herein.These...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240305&DB=EPODOC&locale=&CC=US&NR=11919915B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7GFPVNp6LzBxGkb8Wsa7vuoQhtN4awH7hN9jbaJmPK7IZtkfnXe5d1zhd9CwkcycHlviRfvgO456I-ExFJIYqQ6-bMEnrYlLYeh83Y5pETCVWSpduzO2PzaWJNSvC2_QujdEI_lTgiRlSM8Z6p_Xq1u8QKFLcyfYhesWv52B65gVacjklcjlta4LmtQT_o-5rvu-Oh1nt2SccMoZDl4Xa9RzCadPZbLx79Sln9TintY9gfoLUkO4GSTCpw6G8rr1XgoFs8eGOziL30FAYUulQEKWV4-meb0s8py1M5yxcMsSdDoEdU1y_MRoyoW-sF8RbRDpuvBdFVEClL9p5vXt_TM7hrt0Z-R8epTX_8MB0Pd6uon0M5WSbyAhgXpsFtwxA2j03ZqIdOLEUUCssxGo1aTV5C9W871f8Gr-CIfKooV9Y1lLOPXN5gDs6iW-W8bx_Qjnw
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokbxqyZmb4tl7AMeFhM2CCpfETC8kW0tUYODuC0G_3rvCoov-ta0yaW95Hq_tr_-DuCai8pUhCSFKAKum1NL6EFN2noU1CKbh9VQqJIsna7dGpn3Y2ucg9fvvzBKJ_RDiSNiREUY76narxebSyxfcSuTm_AFu-a3zaHra-vTMYnLcUvz626j3_N7nuZ57migdR9d0jFDKGTVcbveckidl6DTU51-pSx-p5TmHmz30Vqc7kNOxkUoeN-V14qw01k_eGNzHXvJAfQpdKkIUsLw9M9WpZ8TliVyms0YYk-GQI-orp-YjRhRt5Yz4i2iHfa8FERXQaQs2Vu2en1PDuGq2Rh6LR2nNvnxw2Q02KyicgT5eB7LY2BcmAa3DUPYPDKlUwmqkRRhIKyq4TjlsjyB0t92Sv8NXkKhNey0J-277sMp7JJ_Ff3KOoN8-p7Jc8zHaXihHPkF8saRaQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Compounds+and+methods+useful+for+stabilizing+phenylalanine+hydroxylase+mutations&rft.inventor=Konteatis%2C+Zenon+D&rft.inventor=De+Pascalis%2C+Lucrezia&rft.inventor=King%2C+Sandra&rft.inventor=Shook%2C+Brian+C&rft.inventor=Finlay%2C+Heather+Jane&rft.date=2024-03-05&rft.externalDBID=B2&rft.externalDocID=US11919915B2